McLaughlin Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.49M Buy
4,581
+434
+10% +$443K 3.78% 5
2026
Q1
$3.81M Sell
4,147
-244
-6% -$247K 3.65% 3
2025
Q4
$4.72M Buy
+4,391
New +$4.2M 4.22% 3

Other funds holding LLY

McLaughlin Asset Management's LLY Position: Q2 2026 in Review

McLaughlin Asset Management increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $443K and bringing the position to 4,581 shares worth $5.49M. The position accounts for 3.78% of the portfolio, ranked #5.

McLaughlin Asset Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • McLaughlin Asset Management held 4,581 shares of Eli Lilly worth $5.49M as of Q2 2026.
  • McLaughlin Asset Management bought 434 Eli Lilly shares in Q2 2026, an estimated $443K.
  • Eli Lilly made up 3.78% of McLaughlin Asset Management's portfolio in Q2 2026, its #5 holding.
  • McLaughlin Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on McLaughlin Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.